Weill Cornell Medicine has awarded eight grants of $100,000 each to faculty for a variety of research projects on COVID-19, funded by the institution’s Board of Overseers and additional donors. The grants will support studies aimed at understanding fundamental aspects of the disease, the body’s immune response and social determinants of health that affect COVID-19 outcomes.
Dr. Kristen Marks, an associate professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine and associate attending physician at the medical center, leads the team conducting Moderna Therapeutics’s phase 3 COVID-19 vaccine trial at NewYork-Presbyterian/Weill Cornell Medical Center—one of dozens of medical centers around the U.S. where this still-experimental vaccine will be tested.
My wife thinks she got me sick, and I think I got her sick. She was serving on a grand jury—in a room with dozens of people who had sniffles and coughs—and one afternoon she called me and said she’d been sent home with a fever and didn’t feel well.
Home health care workers faced increased risks to their physical, mental and financial well-being while providing essential care to patients during the COVID-19 pandemic, according to researchers at Weill Cornell Medicine, Cornell Tech and Cornell University.
Until very recently, face masks were seldom seen in the United States outside of doctors’ offices, operating rooms and sometimes beauty salons. Now, because of the COVID-19 pandemic, the Centers for Disease Control and Prevention recommends wearing a mask or face covering in public, particularly in situations where social distancing is not possible.
The study of human pluripotent stem cells, which can develop into any cell type in the body, is providing Weill Cornell Medicine and NewYork-Presbyterian investigators with new insights into the virus that causes COVID-19 and how it may infect organs such as the pancreas and liver.
A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases.
Medical students at Weill Cornell Medicine-Qatar (WCM-Q) have answered a call from the Ministry of Public Health (MOPH) for volunteers to help tackle the COVID-19 pandemic.
With cases of COVID-19 spiking in many areas of the United States, and a greater resurgence expected in the fall, whether and how to reopen schools is the subject of strong national interest.
Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have published guidance on how physicians working on the front lines of the COVID-19 pandemic can compassionately inform family members of the painful news that their loved one has died.
Hematology and oncology specialist Dr. Jeffrey Laurence answers questions about the connection between blood clotting and other symptoms of severe COVID-19.
COVID-19 patients have a higher risk of stroke than patients with influenza, according to a study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
As the epicenter of the COVID-19 pandemic moves to Latin America and Africa, Weill Cornell Medicine faculty based in Haiti, a country hard hit by natural disasters and poverty, have developed lessons on what low-resourced countries can do to address and treat the outbreak on the ground.
Epidemiological models of COVID-19 that are used to guide policies on social distancing measures should take into account the special dynamics of the coronavirus’s spread in nursing homes and other long-term care (LTC) facilities.
Critical care physicians, infectious disease specialists and pulmonologists from Weill Cornell Medicine and NewYork-Presbyterian have published a clinical practice guide for managing severe COVID-19 in the New England Journal of Medicine.
The prospect of residency typically brings jitters to newly minted doctors as they prepare to start the next phase of their medical training, and the level and scope of their patient care responsibilities increases. But the transition has become far more complex with numerous unknowns surrounding the ongoing COVID-19 pandemic.
In March, as the COVID-19 pandemic gained a visible foothold in New York City, Weill Cornell Medicine and NewYork-Presbyterian faced a task unlike any they had encountered before: How would they quickly establish a reliable diagnostic testing program to identify patients and healthcare workers who had been exposed to SARS-CoV-2 amid a rapidly escalating public health crisis?
Dr. Monika Safford, chief of the Division of General Internal Medicine at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, finds that obesity is linked to more serious complications from COVID-19, including in younger people.
As doctors face the novel coronavirus that causes COVID-19 with a very limited arsenal of treatments, physicians at Weill Cornell Medicine and NewYork-Presbyterian have rapidly mobilized to test candidate drugs in clinical trials.
Physicians and scientists at Weill Cornell Medicine and NewYork-Presbyterian have rapidly mobilized to confront the COVID-19 pandemic, focusing a broad spectrum of expertise on the critical issues the disease is posing to healthcare workers and public health officials.
